CSF1R and neoplasm: While literature exists on CSF-1R or myeloid inhibition and brain lesions, the findings vary depending on tumor type, metastasis assay (hematogenous, intracranial implantation), inhibitor, dose, and schedule, with the latter often including pretreatment regimens.